http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106146408-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-56 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-513 |
| filingDate | 2015-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-12-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2018-12-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-106146408-B |
| titleOfInvention | The preparation method of 2,5,6 substituted pyrimidines ketone derivatives and its application as anti-hepatic-B virus medicine |
| abstract | The invention discloses a new class of 2,5,6 substituted pyrimidines ketone derivatives, i.e. formula (I) compound, and with good resisting HBV virus activity, the definition of each group is detailed in specification.Furthermore, pharmaceutical composition the invention also discloses the preparation method of the derivative and containing the derivative and described 2,5,6 substituted pyrimidines ketone derivatives and includes described 2, application of the pharmaceutical composition of 5,6 substituted pyrimidines ketone derivatives as Anti-HBV drugs. |
| priorityDate | 2015-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 97.